Assassination Attempt on Franklin D. Roosevelt

Statistically, being the president of the United States is one of the most dangerous jobs in the world, since four have been assassinated (Abraham Lincoln, James Garfield, William McKinley, and John F. Kennedy). In addition to the presidents that have actually been killed while in office, there have been a myriad of unsuccessful attempts to kill U.S. presidents. One of these happened on February 15, 1933, when  Giuseppe Zangara tried to kill President-elect Franklin D. Roosevelt in Miami, Florida. The Assassination Attempt On February 15, 1933, just over two  weeks before Franklin D. Roosevelt was inaugurated as President of the United States, FDR arrived at the Bayfront Park in Miami, Florida around 9 p.m. to give a speech from the back seat of his light-blue Buick. Around 9:35 p.m., FDR finished his speech and had begun talking to some supporters who had gathered around his car when when five shots rang out. Giuseppe Joe Zangara, an Italian immigrant and unemployed bricklayer, had emptied his .32 caliber pistol at FDR. Shooting from about 25 feet away, Zangara was close enough kill FDR. However, since Zangara was only 51, he couldnt see FDR without climbing up on a wobbly chair in order to see over the crowd. Also, a woman named Lillian Cross, who stood near Zangara in the crowd, claimed to have hit Zangaras hand during the shooting. Whether it was because of bad aim, the wobbly chair, or Mrs. Crosss intervention, all five bullets missed FDR. The bullets, however, did hit bystanders. Four received minor injuries, while Chicagos Mayor Anton Cermak was mortally hit in the stomach. FDR Appears Brave During the whole ordeal, FDR appeared calm, brave, and decisive. While FDRs driver wanted to immediately rush the president-elect to safety, FDR ordered the car to stop and pick up the wounded. On their way to the hospital, FDR cradled Cermaks head on his shoulder, offering calming and comforting words which doctors later reported kept Cermak from going into shock. FDR spent several hours at the hospital, visiting each of the wounded. He came back the following day to check on the patients again. At a time when the United States desperately needed a strong leader, the untested president-elect proved himself strong and reliable in the face of crisis. Newspapers reported on both FDRs actions and demeanor, putting faith in FDR before he even stepped into the presidential office. Why Did Zangara Do It? Joe Zangara was caught immediately and taken into custody. In an interview with officials after the shooting, Zangara stated that he wanted to kill FDR because he blamed FDR and all rich people and capitalists for his chronic stomach pain. At first, a judge sentenced Zangara to 80 years in prison after Zangara pleaded guilty, saying, I kill capitalists because they kill me, stomach like drunk man. No point living. Give me electric chair.* However,  when Cermak died of his wounds on March 6, 1933 (19 days after the shooting and two days after FDRs inauguration), Zangara was charged with first-degree murder and sentenced to death. On March 20, 1933, Zangara strode to  the electric chair  unaided and then plunked himself down. His last words were Pusha da button! *Joe Zangara as quoted in Florence King, A Date Which Should Live in Irony,  The American Spectator  February 1999: 71-72.

Aristotle And Cherry s View On Anger Essay - 1522 Words

â€Å"Nicomachean Ethics† written by Aristotle argues that to be a virtuous character, one should stay away from both extremes. Aristotle introduces the idea of virtue and where it comes from, deficiency and excess and such to pinpoint what it means to be a virtuous character. â€Å"Anger is not a bad word† lectured by Myisha Cherry argues that anger is not always destructive and does not always bring harms; it is also valuable, important, and necessary to pursuit for justice. Cherry believes that anger at injustices only recognizes the wrongdoing. I will explain Aristotle and Cherry’s perspective on anger. I will argue that Aristotle will agree with Cherry’s statement and that I agree with Cherry’s argument because I believe expressing anger show that you care, it is a type of stress reliever and it is a type of persistence. First, I will explain Aristotle’s â€Å"Nichomachean Ethics† along with mean, deficiency and excess and virtuous character. Aristotle said that virtue is not inherent in humans, but it is more like a trait that is actualized by our habits. A virtue is not a feeling since a person could feel brave but does not act brave. It is a disposition to do certain actions and feel certain feelings. A disposition is an inclination, it is a characteristic that urges to act or feel in a certain way. It is not just doing a given action at a given time. Rather or not, one develops into a virtuous character; it all depends on what kinds of habits one has. Children are developing theseShow MoreRelatedThe s Dramatic Presentation Of Sir Thomas More As A Common, Heroic Man For All Seasons1273 Words   |  6 PagesCourse Date Bolt’s Dramatic Presentation of Sir Thomas More as a Common, yet Heroic Man Robert Oxton Bolt was an English teacher at a prestigious private school and wrote plays and scripts for radio dramas. The success came in 1957 with the play â€Å"Cherry Blossom† and allowed the young playwright to leave the teaching profession and to concentrate on work. His next play, â€Å"Man for All Seasons,† dedicated to the life of the famous statesman Sir Thomas More became very popular in the theatrical worldRead Morewisdom,humor and faith19596 Words   |  79 Pages WISDOM, HUMOR, AND FAITH: A HISTORICAL VIEW Walter G. Moss Table of Contents (with links) Walter G. Moss 1 Table of Contents (with links) 1 Wisdom, Perspective, and Values 2 Humor’s Contribution to Wisdom 4 Humor and Wisdom in Europe: Some Highlights 5 Renaissance Humor: Erasmus, Rabelais, Cervantes, Shakespeare 5 Two European Russians: Anton Chekhov and Vladimir Soloviev 9 Reflections on Humor from Nietzsche to the Theatre of the Absurd 12 Humor and Wisdom in the United States: Lincoln, Beecher

Pharmacology Basal Insulin

Question: Describe about the Basal Insulin? Answer: The human system naturally produces various quantities of insulin at various times. Slighter and steady amounts are generated between lunch and overnight, sometimes termed as background or basal insulin. Larger quantities are generated when individual eat, termed as bolus insulin (Lillian F. Lien, 2011). Collectively, these can manage the level of glucose within the blood stream throughout the day (Ahmad, 2014). When the human system cannot make adequate amount of insulin, for instance during the diabetic conditions, individual may require taking manufactured insulin from outside as dosage modes to obtain the equal effect. Basal insulin comprises longer functioning and intermediate functioning insulin. These types of insulin lower the level of blood glucose more gradually and stay longer than the rapid acting insulin. A physician can recommend taking basal dosage once or twice in a day. Detemir insulin is considered as soluble, recombinant and long-functioning insulin analog that is produced by modification in chemical structure of normal insulin. Fatty acid acylation increases the detemir affinity to albumin, which allows for prolonged period of effect by delayed absorption as a consequence of albumin binding in plasma and adipose tissue of subcutaneous region. Insulin detemir is soluble at neutral pH and is present as liquid after subcutaneous injection, diminish absorption viability and raise surface area, unlike NPH insulin and glargine (Garg, Rosenstock and Ways, 2005). Detemir insulin has equal potential to insulin NPH. Detmir has certain advantages over the NPH insulin and glargine. These advantages are: once or twice regular administration, less inconsistency in patient responses, a smaller amount of weight gain, improvement or similarity in glycemic control and reduction in occurrence of hypoglycemia comprising both severe and night time hypoglycemia. Accor ding to the scientists Frier, Jones and Heise (2013) Insulin detemir therapy offered better or similar glycemic control, lesser within-subject inconsistency, lower or similar hypoglycemia frequency and a lesser amount of weight gain while compared with isophane insulin (Frier, Russell-Jones and Heise, 2013). Insulin degludec is a basal insulin analogue, which is even more long-acting and was developed by Novo Nordisk (NASRALLAH, NASRALLAH and L. Raymond Reynolds, 2012). A doctor can recommend taking this insulin via subcutaneous injection once a day to control the level of the blood sugar. Scientists Garber et al. (2012) have performed a basal-bolus type II trial with insulin degludec (Garber et al., 2012). In the basal-bolus type II trial insulin degludec was examined as a substitute to glargine insulin in type II diabetic patients. Almost 995patients were received either glargine or degludec, along with mealtime aspart insulin or pioglitazone (Chen, 2005). Patients who were involved in this trial had an average of 8.3-8.4% of HbA1c and almost 50% patients were under the treatment of oral anti-diabetic and basal-bolus insulin medications (Garber et al., 2012). At the end of the research study it was found that insulin degludec is more efficient than insulin glargine. It offers good amou nt of HbA1c lowering effect. Overall hypoglycaemia rates were significantly low with degludec, along with the incidences of night time hypoglycaemia. References Ahmad, K. (2014). Insulin sources and types: a review of insulin in terms of its mode on diabetes mellitus.Journal of Traditional Chinese Medicine, 34(2), pp.234-237. Chen, J. (2005). Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with type 1 diabetes.European Journal of Endocrinology, 153(6), pp.907-913. Frier, B., Russell-Jones, D. and Heise, T. (2013). A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review.Diabetes Obes Metab, 15(11), pp.978-986. Garber, A., King, A., Prato, S., Sreenan, S., Balci, M., Muoz-Torres, M., Rosenstock, J., Endahl, L., Francisco, A. and Hollander, P. (2012). Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.The Lancet, 379(9825), pp.1498-1507. Garg, S., Rosenstock, J. and Ways, K. (2005). Optimized Basal-Bolus Insulin Regimens In Type 1 Diabetes: Insulin Glulisine Versus Regular Human Insulin In Combination With Basal Insulin Glargine.Endocrine Practice, 11(1), pp.11-17. Lillian F. Lien, M. (2011).Glycemic Control in the Hospitalized Patient. Springer Science+Business Media, LLC. Nasrallah, Nasrallah, and L. Raymond Reynolds, (2012). Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?.CMED, p.31.